# Regional Anesthesia for Major Surgery of the Foot. Levobupivacaïne Ropivacaine 0.5% Versus 0.5% in the Sciatic Block Through médiofémorale

> **NCT00956709** · PHASE4 · TERMINATED · sponsor: **Nantes University Hospital** · enrollment: 35 (actual)

## Conditions studied

- Nerve Block

## Interventions

- **DRUG:** levobupivacaïne 0,5 %
- **DRUG:** ropivacaïne 0,5 %

## Key facts

- **NCT ID:** NCT00956709
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2016-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956709, "Regional Anesthesia for Major Surgery of the Foot. Levobupivacaïne Ropivacaine 0.5% Versus 0.5% in the Sciatic Block Through médiofémorale". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00956709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*